Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store?

What's in Store for DENTSPLY SIRONA (XRAY) in Q1 Earnings?

What's in Store for Cardinal Health (CAH) in Q3 Earnings?

Cencora (COR) to Report Q2 Earnings: What's in the Cards?

NovoCure (NVCR) Expected to Beat Earnings Estimates: Should You Buy?

NovoCure (NVCR) Expected to Beat Earnings Estimates: Should You Buy?

Results of Novocure’s METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024

Medpace (MEDP) Beats Q1 Earnings Estimates

Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024

NovoCure (NVCR) Moves to Buy: Rationale Behind the Upgrade

NovoCure (NVCR) Moves to Buy: Rationale Behind the Upgrade

Novocure to Report First Quarter 2024 Financial Results

Why NovoCure Stock Soared 18.3% This Week

Why Novocure Stock Is Jumping Today

NovoCure (NVCR) Soars 12.0%: Is Further Upside Left in the Stock?

NovoCure (NVCR) Soars 12.0%: Is Further Upside Left in the Stock?

Novocure Surges 12% On Brain Tumors Study; But Some Analysts Are Bearish

Novocure's lung cancer therapy succeeds in late-stage trial

UPDATE 1-Novocure's lung cancer therapy succeeds in late-stage trial

Novocure's device shown to slow cancer progression in the brain in trial